Literature
SureSeq myPanel™ NGS Custom Cancer Panels
Type: Product profile
Assessment of the performance of a hybridisation-based NGS enrichment panel with as little as 10 ng of severely formalin-compromised DNA
Presented at AMP 2018, this poster illustrates the excellent performance of a hybridisation-based NGS enrichment panel, in conjunction with an FFPE repair mix.
Type: Poster
Beyond FISH, SNVs and indels – improved resolution of translocation detection using next generation sequencing (NGS)
Presented at AMP 2018, this poster demonstrates how the superior uniformity of coverage of the hybridisation-based approach of the SureSeq™ protocol in combination with a SureSeq myPanel™ NGS Custom panel reliably detects somatic BCR-ABL1 translocations.
Type: Poster
Notes from the field: Cytocell Application Specialist, Gothami Fonseka
Type: Article
Notes from the Field: Cytocell Field Application Scientist, Ashley Hart
Type: Article
SureSeq™ Interpret Software
Type: Product profile
The Analysis of FFPE Samples by Next-Generation Sequencing (NGS) of Key Genes for Research into Breast and Ovarian Cancer
Presented at AMP Europe 2018, this poster illustrates the confident detection of germline and somatic variants in key cancer-related genes including BRCA1 and TP53.
Type: Poster
CytoSure™ Cancer +SNP Arrays
Type: Product profile
Interview: Erica Phillips, CG (ASCP), Clinical Cytogenetics Supervisor, Duke University Health System
Custom Genomic Research Solutions
OGT's custom NGS panels, custom arrays and custom FISH probes give researchers the ability to react to new discoveries, modify research workflows, and target specific regions in a fast-changing genomics research environment.
Type: Brochure
What’s wrong with my arrays?
Wet-lab processing is key to achieving the highest quality array data – find the solution to improve your data quality with our poster.
Type: Poster
Greater confidence in calling low-frequency variants – from as little as 10ng of severely formalin-compromised DNA
In this study, carried out in collaboration with Horizon Discovery, formalin-compromised DNA (fcDNA) samples of differing severity were repaired with the SureSeq™ FFPE repair mix and sequenced using a SureSeq custom hybridisation-based panel.
Type: Application note
SureSeq myPanel™ NGS Custom Cancer Panels Full Gene List
We now have 120 genes available for our SureSeq myPanel NGS Custom Cancer Panels. View and download a complete list of available cancer gene content.
Type: Gene list
SureSeq myPanel™ NGS Custom Prostate Cancer Panel
Type: Product profile
The accurate detection by next-generation sequencing (NGS) of difficult to sequence genes (CALR, CEBPA, FLT3) associated with myeloid disorders using a hybridisation-based enrichment approach
Presented at AMP 2017, this poster illustrates how the excellent coverage uniformity obtained using hybridisation-based enrichment and the SureSeq™ myPanel NGS Custom AML Panel can be successful in sequencing traditionally difficult genes.
Type: Poster
Find out more
For more information about any OGT product or service, please contact us.